Jacobs Levy Equity Management, Inc Icosavax, Inc. Transaction History

Jacobs Levy Equity Management, Inc

  • $24.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$5.62 - $11.51 $381,002 - $780,308
-67,794 Reduced 49.25%
69,851 $405,000
Q4 2022

Feb 14, 2023
SELL
$2.32 - $10.97 $254,817 - $1.2 Million
-109,835 Reduced 44.38%
137,645 $1.09 Million
Q3 2022

Nov 15, 2022
BUY
$3.09 - $9.21 $261,101 - $778,235
84,499 Added 51.85%
247,480 $782,000
Q2 2022

Aug 15, 2022
BUY
$5.7 - $10.33 $928,991 - $1.68 Million
162,981 New
162,981 $934,000

Others Institutions Holding ICVX

# of Institutions
2
Shares Held
1.37M
Call Options Held
0
Put Options Held
0
View Full List

About Icosavax, Inc.

ICVX Quotes by TradingView
  • Ticker ICVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,885,200
  • Description
  • Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...
More about ICVX
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email